Proteomics in human disease: Cancer, heart and infectious diseases

In recent years, genomics has increased the understanding of many diseases. Proteomics is a rapidly growing research area that encompasses both genetic and environmental factors. The protein composition represents the functional status of a biological compartment. The five approaches presented here resulted in the detection of disease‐associated proteins. Calgranulin B was upregulated in colorectal cancer, and hepatoma‐derived aldose reductase‐like protein was reexpressed in a rat model during hepatocarcinogenesis. In these two investigations, attention was focused on one protein, obviously differing in amount, directly after two‐dimensional electrophoresis (2‐DE). Additional methods, such as enzyme activity measurements and immunohistochemistry, confirmed the disease association of the two candidates resulting from 2‐DE subtractive analysis. The following three investigations take advantage of the holistic potential of the 2‐DE approach. The comparison of 2‐DE patterns from dilated cardiomyopathy patients with those of controls revealed 25 statistically significant intensity differences, from which 12 were identified by amino acid analysis, Edman degradation or matrix‐assisted laser desorption/ionization‐mass spectrometry (MALDI‐MS). A human myocardial 2‐DE database was constructed, containing 3300 protein spots and 150 identified protein species. The number of identified proteins was limited by the capacity of our group, rather than by the principle of feasibility. Another field where proteomics proves to be a valuable tool in identifying proteins of importance for diagnosis is proteome analysis of pathogenic microorganisms such as Borrelia burgdorferi (Lyme disease) and Toxoplasma gondii (toxoplasmosis). Sera from patients with early or late symptoms of Lyme borreliosis contained antibodies of various classes against about 80 antigens each, containing the already described antigens OspA, B and C, flagellin, p83/100, and p39. Similarly, antibody reactivity to seven different marker antigens of T. gondii allowed differentiation between acute and latent toxoplasmosis, an important diagnostic tool in both pregnancy and immunosuppressed patients.

[1]  R. C. Johnson,et al.  Immunoblot interpretation criteria for serodiagnosis of early Lyme disease , 1995, Journal of clinical microbiology.

[2]  E Fleck,et al.  Representation of amino acid sequences as two‐dimensional point patterns , 1997, Electrophoresis.

[3]  D. Rickwood,et al.  The heterogeneity of mouse-chromatin nonhistone proteins as evidenced by two-dimensional polyacrylamide-gel electrophoresis and ion-exchange chromatography. , 1974, European journal of biochemistry.

[4]  M. Wilm,et al.  Analytical properties of the nanoelectrospray ion source. , 1996, Analytical chemistry.

[5]  E. Müller,et al.  High‐performance human myocardial two‐dimensional electrophoresis database: Edition 1996 , 1996, Electrophoresis.

[6]  D. Arnott,et al.  An integrated approach to proteome analysis: identification of proteins associated with cardiac hypertrophy. , 1998, Analytical biochemistry.

[7]  J R Scherrer,et al.  The MELANIE project: From a biopsy to automatic protein map interpretation by computer , 1991, Electrophoresis.

[8]  P. Edman,et al.  A method for the determination of amino acid sequence in peptides. , 1949, Archives of biochemistry.

[9]  L. David Sibley,et al.  Virulent strains of Toxoplasma gondii comprise a single clonal lineage , 1992, Nature.

[10]  S. Salzberg,et al.  Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi , 1997, Nature.

[11]  Eckart Fleck,et al.  Dilated cardiomyopathy‐associated proteins and their presentation in a WWW‐accessible two‐dimensional gel protein database , 1997, Electrophoresis.

[12]  M J Dunn,et al.  The human myocardial two‐dimensional gel protein database: Update 1994 , 1994, Electrophoresis.

[13]  Sheung Tat Fan,et al.  Identification and Characterization of a Novel Human Aldose Reductase-like Gene* , 1998, The Journal of Biological Chemistry.

[14]  J. Klose,et al.  Systematic analysis of the total proteins of a mammalian organism: Principles, problems and implications for sequencing the human genome , 1989, Electrophoresis.

[15]  P. Jungblut,et al.  Protein analysis on a genomic scale. , 1995, Journal of Biotechnology.

[16]  Denis F. Hochstrasser,et al.  Clinical and Biomedical Applications of Proteomics , 1997 .

[17]  E. Fleck,et al.  Characterization of myocardial protein composition in dilated cardiomyopathy by two-dimensional gel electrophoresis. , 1994, European heart journal.

[18]  E. Müller,et al.  Resolution power of two‐dimensional electrophoresis and identification of proteins from gels , 1996, Electrophoresis.

[19]  L. Sibley,et al.  Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. , 1995, The Journal of infectious diseases.

[20]  R. Seifert,et al.  Analysis by high-resolution two-dimensional electrophoresis of differentiation-dependent alterations in cytosolic protein pattern of HL-60 leukemic cells. , 1990, Journal of biochemical and biophysical methods.

[21]  G. Scheele,et al.  Two-dimensional gel analysis of soluble proteins. Charaterization of guinea pig exocrine pancreatic proteins. , 1975, The Journal of biological chemistry.

[22]  J I Garrels,et al.  Quantitative exploration of the REF52 protein database: Cluster analysis reveals the major protein expression profiles in responses to growth regulation, serum stimulation, and viral transformation , 1990, Electrophoresis.

[23]  A. Otto,et al.  Further characterization of a rat hepatoma-derived aldose-reductase-like protein--organ distribution and modulation in vitro. , 1997, European journal of biochemistry.

[24]  M. Dunn,et al.  Construction of HSC‐2DPAGE: A two‐dimensional gel electrophoresis database of heart proteins , 1997, Electrophoresis.

[25]  M. Mann,et al.  Electrospray ionization for mass spectrometry of large biomolecules. , 1989, Science.

[26]  L. D. Ward,et al.  Two‐dimensional electrophoretic analysis of proteins expressed by normal and cancerous human crypts: Application of mass spectrometry to peptide‐mass fingerprinting , 1994, Electrophoresis.

[27]  Bernhard Spengler,et al.  Metastable decay of peptides and proteins in matrix‐assisted laser‐desorption mass spectrometry , 1991 .

[28]  E. Fleck,et al.  Identification of human myocard proteins separated by two‐dimensional electrophoresis , 1992, Electrophoresis.

[29]  E Fleck,et al.  The construction of the World Wide Web‐accessible myocardial two‐dimensional gel electrophoresis protein database “HEART‐2DPAGE”: A practical approach , 1996, Electrophoresis.

[30]  M. Karas,et al.  Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. , 1988, Analytical chemistry.

[31]  R. Saavedra,et al.  Monoclonal antibodies identify new Toxoplasma gondii soluble antigens. , 1990, Hybridoma.

[32]  E. Müller,et al.  Identification and characterization of heat shock protein 27 protein species in human myocardial two‐dimensional electrophoresis patterns , 1997, Electrophoresis.

[33]  K. Walls,et al.  Comparative antigenic study of Besnoitia jellisoni, B. Panamenis and five Toxoplasma gondii isolates. , 1968, Journal of immunology.

[34]  M. Yacoub,et al.  A human myocardial two‐dimensional electrophoresis database: Protein characterisation by microsequencing and immunoblotting , 1992, Electrophoresis.

[35]  Jiří Vohradský,et al.  Adaptive classification of two‐dimensional gel electrophoretic spot patterns by neural networks and cluster analysis , 1997, Electrophoresis.

[36]  Marc R. Wilkins,et al.  Proteome Research: New Frontiers in Functional Genomics , 1997, Principles and Practice.

[37]  M. Wilkins,et al.  Progress with gene‐product mapping of the Mollicutes: Mycoplasma genitalium , 1995, Electrophoresis.

[38]  A. Steere,et al.  Western blotting in the serodiagnosis of Lyme disease. , 1993, The Journal of infectious diseases.

[39]  S. Tsuchida,et al.  Glutathione transferases and cancer. , 1992, Critical reviews in biochemistry and molecular biology.

[40]  Joachim Klose,et al.  Two‐dimensional electrophoresis of proteins: An updated protocol and implications for a functional analysis of the genome , 1995, Electrophoresis.

[41]  A. Macela,et al.  Overexpression of calcium-binding protein calgranulin B in colonic mucosal diseases. , 1997, Clinica chimica acta; international journal of clinical chemistry.

[42]  M. Harrington,et al.  The assay development of a molecular marker for transmissible spongiform encephalopathies , 1997, Electrophoresis.

[43]  B. Wilske,et al.  Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato , 1997, Journal of Clinical Microbiology.

[44]  Keiichiro Suzuki,et al.  Induction of Aldose Reductase Gene Expression in LEC Rats during the Development of the Hereditary Hepatitis and Hepatoma , 1996, Japanese journal of cancer research : Gann.

[45]  Eckart Fleck,et al.  Protein composition of the human heart: The construction of a myocardial two‐dimensional electrophoresis database , 1994, Electrophoresis.

[46]  J. Hayes,et al.  An ethoxyquin-inducible aldehyde reductase from rat liver that metabolizes aflatoxin B1 defines a subfamily of aldo-keto reductases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[47]  K. Biemann,et al.  Characterization by tandem mass spectrometry of structural modifications in proteins. , 1987, Science.

[48]  A. Otto,et al.  Identification of tumor-associated protein variants during rat hepatocarcinogenesis. Aldose reductase. , 1994, The Journal of biological chemistry.

[49]  R D Appel,et al.  Inside SWISS‐2DPAGE database , 1995, Electrophoresis.

[50]  P. O’Farrell High resolution two-dimensional electrophoresis of proteins. , 1975, The Journal of biological chemistry.

[51]  E. Maser,et al.  Xenobiotic carbonyl reduction and physiological steroid oxidoreduction. The pluripotency of several hydroxysteroid dehydrogenases. , 1995, Biochemical pharmacology.